SEC Form 4 · accession 0001638599-17-001155
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Smolinski
Officer — Chief Commercial Officer
Period of report
Nov 17, 2017
Accepted (ET)
Nov 20, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $10.23 | Nov 17, 2017 | A | 80,000 | A | — | Nov 16, 2027 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1This option vests as to 25% of the shares on October 26, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.